NextCure, Inc. (NXTC) Tops Q1 EPS by 9c

NextCure, Inc. (NASDAQ: NXTC) reported Q1 EPS of ($0.58), $0.09 better than the analyst estimate of ($0.67).

For earnings history and earnings-related data on NextCure, Inc. (NXTC) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• AMC Entertainment prices $200M stock offering to redeem senior notes
• Deutsche Bank Starts Tandem Diabetes Care (TNDM) at Hold